Katrin Conen

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Hans‐Georg Wirsching, Ghazaleh Tabatabai, Ulrich Roelcke et al. · Annals of Oncology · 2018 · 85 citations · Full text

Planning and reporting of quality-of-life outcomes in cancer trials

Stefan Schandelmaier, Katrin Conen, Erik von Elm et al. · Annals of Oncology · 2015 · 65 citations · Full text

Quality Of Life, Medicine, Clinical Trials +8

MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial

Hans‐Georg Wirsching, Ulrich Roelcke, Jonathan Weller et al. · Clinical Cancer Research · 2020 · 31 citations · Full text

Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort

Katrin Conen, Raphael Hagmann, Viviane Hess et al. · Journal of Cancer · 2016 · 30 citations · Full text

Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes

Thomas Hundsberger, Andreas F. Hottinger, Ulrich Roelcke et al. · Journal of Neuro-Oncology · 2015 · 21 citations

Neuro-oncology, Multicentre National Approach, Tumoral Pathology +12